|
|
| (5 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Carvedilol#Contraindications]] |
| {{Carvedilol}}
| |
| {{CMG}}; {{AE}} {{AZ}}
| |
| | |
| ==Contraindications==
| |
| | |
| COREG is '''contraindicated''' in the following conditions:
| |
| | |
| :*[[Bronchial asthma or related bronchospastic conditions. Deaths from status asthmaticus have been reported following single doses of COREG.
| |
| :*[[AV block]] (Second- or third-degree) .
| |
| :*[[Sick sinus syndrome.
| |
| :*[[Severe bradycardia (unless a permanent pacemaker is in place).
| |
| :*[[Cardiogenic shock]] or who have decompensated heart failure requiring the use of intravenous inotropic therapy. Such patients should first be weaned from intravenous therapy before initiating COREG.
| |
| :*Severe hepatic impairment.
| |
| :*Serious [[hypersensitivity]] reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = |first = | title = COREG (CARVEDILOL) TABLET, FILM COATED [GLAXOSMITHKLINE LLC] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c57982f2-c7da-488a-7ea9-b9609439ac68#nlm34089-3 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==References==
| |
| {{Reflist}}
| |
| | |
| {{FDA}}
| |
|
| |
|
| | [[Category:Beta Blockers]] |
| | [[Category:Cardiovascular Drugs]] |
| [[Category:Drugs]] | | [[Category:Drugs]] |